This naturally occurring insertion results in a significant 1.8-fold lower methylation of the gene in normal samples, and a 2.1-fold to 3.1-fold lower methylation in cancer that we have traced to the creation of a new Sp1/Sp3 binding site. This evidence concerns the gene SP1 and cancer.